Ceramide synthase 1
sphingosine N-acyltransferase activity
Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy.
<h4>Objective</h4>Alterations of sphingolipid metabolism are implicated in the pathogenesis of many neurodegenerative disorders.<h4>Methods</h4>We identified a homozygous nonsynonymous mutation in CERS1, the gene encoding ceramide synthase 1, in 4 siblings affected by a progressive disorder with myoclonic epilepsy and dementia. CerS1, a transmembrane protein of the endoplasmic reticulum (ER), catalyzes the biosynthesis of C18-ceramides.<h4>Results</h4>We demonstrated that the mutation decreases C18-ceramide levels. In addition, we showed that downregulation of CerS1 in a neuroblastoma cell line triggers ER stress response and induces proapoptotic pathways.<h4>Interpretation</h4>This study demonstrates that impairment of ceramide biosynthesis underlies neurodegeneration in humans.